Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can virtual reality help curb gambling cravings?

NCT ID NCT04467502

Disease control Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares virtual reality exposure therapy (VRET) to standard imaginal exposure therapy for people with gambling disorder. Both treatments are combined with cognitive-behavioral therapy (CBT) over 12 sessions. The goal is to see if VRET is as good as or better than imaginal exposure at reducing gambling cravings and symptoms. The trial involves 124 participants and will track outcomes for up to a year after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
virtual reality exposure therapy
What this could lead to
If successful, this could offer a more practical and motivating way to deliver exposure therapy for gambling disorder, potentially improving treatment access and outcomes.
What could go wrong
This is a relatively early-stage trial with 124 participants, and virtual reality therapy may not be more effective than standard imaginal exposure. The novelty of VR could also wear off, affecting long-term results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 124 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2023

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Seek treatment for GD within one of health care facilities participating in the research (first request for treatment and not patients already receiving treatment for gambling disorder in the care center). * Meet a current diagnosis of gambling disorder according to DSM-5 criteria and with a South Oaks Gambling Screen (SOGS) score ≥ 5 * Meet a casino gambling behavior with a casino gambling frequency ≥ 1 time every two months during the last 12 months * Have a sufficient understanding of French for therapy * Beneficiary of the French social security system * Give an informed consent to participate * Willing to comply with all study procedures and duration Exclusion Criteria: * Visual disturbance making impossible the use of virtual reality equipment (e.g. advanced retinal degeneration, central scotoma, age-related macular degeneration) * Pregnant woman * Minor or adult under guardianship, conservatorship, under judicial protection, persons deprived of their liberty * Balance disorder (e.g. cerebellar disorder, inner ear disorder) * Photosensitive epilepsy * Refusal to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gambling disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pathological gambling

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gambling disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Association GREID ValenciennesCSAPA

    NOT_YET_RECRUITING

    Valenciennes, France

  • Assoriation Cédragir Lomme CSAPA

    NOT_YET_RECRUITING

    Lomme, France

  • CH Boulogne sur mer CSAPA

    NOT_YET_RECRUITING

    Boulogne-sur-Mer, France

  • CH Seclin Carvin CSAPA

    RECRUITING

    Seclin, France

  • CH de Saint Amand les Eaux

    NOT_YET_RECRUITING

    Saint-Amand-les-Eaux, France

  • CH de l'arrondissement de Montreuil / CSAPA

    NOT_YET_RECRUITING

    Montreuil-sur-Mer, France

  • CHU Amiens-Picardie

    NOT_YET_RECRUITING

    Amiens, France

  • CHU Rouen

    NOT_YET_RECRUITING

    Rouen, France

  • CHU de Caen

    NOT_YET_RECRUITING

    Caen, France

  • Hôpital Fontan, CHU lille

    NOT_YET_RECRUITING

    Lille, 59000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.